INS and Hypoglycemia: Asian people with T2DM face the risk of hypoglycaemia, weight gain, difficulties in reducing PPG, and the complexities of subcutaneous injection, dose titration, and regular self‐monitoring of blood glucose associated with basal insulin therapy.